Great Merger, Guys. Here's $1 Million | GenomeWeb

Frank D'Amelio and Ian Read, respectively the CFO and the head of biopharmaceuticals at Pfizer, will each receive about a million dollar bonus, according to the Wall Street Journal Health Blog. They showed, according to the board's compensation committee, "devoted extraordinary efforts and made extraordinary contributions" to the Pfizer-Wyeth merger. The Health Blog notes that Pfizer plans to eliminate 20,000 jobs due to the merger.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.